Being Well with Forrest Hanson and Dr. Rick Hanson Psychedelic-Assisted Therapy with Dr. Albert Garcia Romeu
18 snips
Aug 15, 2022 From LSD’s early research days to today’s clinical trials, explore why psychedelics are drawing attention for addiction, depression, and PTSD. Discover how psilocybin can reshape perception and emotion, what researchers are learning about the brain, and what a carefully supported therapy session involves. The conversation also ventures into spirituality, personal growth, safety, and access.
AI Snips
Chapters
Transcript
Episode notes
Classic Psychedelics Work Through Serotonin 2A Pathways
- Classic psychedelics (psilocybin, LSD, DMT, mescaline) act primarily as serotonin 2A receptor agonists and are historically labeled "mind-manifesting."
- Johns Hopkins and other labs refocused research after prohibition, studying therapeutic uses for mood and substance-use disorders with psilocybin and MDMA leading the recent surge.
High Dose Sessions Unlock Deep Personal Material
- High-dose classic psychedelic sessions produce perceptual changes, heightened bodily awareness, autobiographical recall, emotional shifts, and sometimes ego-dissolution or mystical unity.
- These subjective effects can surface unresolved memories and feelings, making them therapeutically useful when integrated with support.
Psychedelics Can Reboot Maladaptive Brain Patterns
- Psychedelics appear to disrupt entrenched patterns by altering brain dynamics and enabling a post-experience 'reboot' where dysfunctional patterns are blunted.
- That plastic window, paired with therapeutic support, increases chances a person will form healthier behaviors and perspectives.